Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients
暂无分享,去创建一个
Melissa A Troester | Jason R. Pirone | Lisa A Carey | Jason R Pirone | L. Carey | Sendurai A Mani | M. Troester | R. Lubet | K. Amos | Patricia Casbas-Hernández | Keith D Amos | Erick Román-Pérez | J. Rein | Ronald A Lubet | Erick Román-Pérez | Patricia Casbas-Hernández | Jessica Rein | Jessica S. Rein
[1] D. Radisky,et al. Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[2] C. Perou,et al. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features , 2011, BMC Medical Genomics.
[3] J. Parker,et al. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. , 2009, The Journal of clinical investigation.
[4] Jason R. Pirone,et al. Activation of Host Wound Responses in Breast Cancer Microenvironment , 2009, Clinical Cancer Research.
[5] R. Kalluri,et al. Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.
[6] Zhiyuan Hu,et al. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Kakajan Komurov,et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.
[8] Andrew H. Beck,et al. The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma , 2009, Clinical Cancer Research.
[9] A. Neugut,et al. Mutations in p53, p53 protein overexpression and breast cancer survival , 2008, Journal of Cellular and Molecular Medicine.
[10] D. Proia,et al. Reconstruction of human mammary tissues in a mouse model , 2006, Nature Protocols.
[11] Robert A. Weinberg,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[12] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[13] Antonio de las Morenas,et al. Gene Expression Profiles of Estrogen Receptor–Positive and Estrogen Receptor–Negative Breast Cancers Are Detectable in Histologically Normal Breast Epithelium , 2010, Clinical Cancer Research.
[14] S. Chanock,et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses , 2006, Human Genetics.
[15] Y. Okada. Volume expansion-sensing outward-rectifier Cl- channel: fresh start to the molecular identity and volume sensor. , 1997, The American journal of physiology.
[16] Isabelle Bedrosian,et al. Cyclin E and survival in patients with breast cancer. , 2002, The New England journal of medicine.
[17] M. Sporn,et al. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. , 1990, Science.
[18] Jason I. Herschkowitz,et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.
[19] Andrew H. Beck,et al. Endogenous Versus Tumor-Specific Host Response to Breast Carcinoma: A Study of Stromal Response in Synchronous Breast Primaries and Biopsy Site Changes , 2010, Clinical Cancer Research.
[20] C. Perou,et al. Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers , 2010, Molecular Cancer Research.
[21] Yufeng Liu,et al. Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures , 2011, BMC Medical Genomics.
[22] A. Mannermaa,et al. Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression , 2009, BMC Cancer.
[23] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[24] Andrew H. Beck,et al. The fibromatosis signature defines a robust stromal response in breast carcinoma , 2008, Laboratory Investigation.
[25] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[26] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] Andrew H. Beck,et al. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ , 2010, Breast Cancer Research and Treatment.
[28] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[29] M. Barcellos-Hoff,et al. Transforming growth factor-β in breast cancer: too much, too late , 2009, Breast Cancer Research.
[30] F. Strutz,et al. Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.
[31] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[32] N. Hynes,et al. Key signalling nodes in mammary gland development and cancer: Myc , 2009, Breast Cancer Research.
[33] C. Heaphy,et al. Mammary field cancerization: molecular evidence and clinical importance , 2009, Breast Cancer Research and Treatment.
[34] M. Washington,et al. TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.
[35] Kimberly S. Butler,et al. Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors , 2011, International journal of cancer.
[36] Kazuhiko Aoyagi,et al. Artificially Induced Epithelial-Mesenchymal Transition in Surgical Subjects: Its Implications in Clinical and Basic Cancer Research , 2011, PloS one.
[37] William C Hines,et al. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.
[38] F. Pépin,et al. Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.
[39] P. V. van Diest,et al. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. , 2008, Biochemical and biophysical research communications.
[40] Hein Putter,et al. Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients , 2011, Breast Cancer Research and Treatment.
[41] V. Borges,et al. Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer , 2009, Breast Cancer Research.
[42] T. Yeatman,et al. Evaluation of malignancy-risk gene signature in breast cancer patients , 2010, Breast Cancer Research and Treatment.
[43] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[44] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[45] Xiao-Jun Ma,et al. Gene expression profiling of the tumor microenvironment during breast cancer progression , 2009, Breast Cancer Research.
[46] Adrian V. Lee,et al. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.